Invesco Ltd. Collegium Pharmaceutical, Inc Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Invesco Ltd. holds 1,632,339 shares of COLL stock, worth $52.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,632,339

Previous 1,775,760 8.08%

Holding current value

$52.7 Million

Previous $50.9 Million 4.23%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$28.04 - $33.91 $4.02 Million - $4.86 Million	-143,421 Reduced 8.08%	1,632,339 $48.7 Million
Q4 2024 Feb 13, 2025	BUY	$28.61 - $41.86 $8.28 Million - $12.1 Million	289,335 Added 19.47%	1,775,760 $50.9 Million
Q3 2024 Nov 12, 2024	SELL	$31.4 - $39.07 $6.91 Million - $8.6 Million	-220,185 Reduced 12.9%	1,486,425 $57.4 Million
Q2 2024 Aug 13, 2024	BUY	$31.36 - $39.99 $2.35 Million - $3 Million	74,954 Added 4.59%	1,706,610 $55 Million
Q1 2024 May 14, 2024	BUY	$31.23 - $40.91 $5.93 Million - $7.77 Million	190,039 Added 13.18%	1,631,656 $63.3 Million
Q4 2023 Feb 12, 2024	BUY	$21.16 - $30.8 $5.97 Million - $8.69 Million	282,013 Added 24.32%	1,441,617 $44.4 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $419,080 - $479,287	19,740 Added 1.73%	1,159,604 $25.9 Million
Q2 2023 Aug 11, 2023	SELL	$21.06 - $24.0 $5,033 - $5,736	-239 Reduced 0.02%	1,139,864 $24.5 Million
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $1.66 Million - $2.15 Million	72,050 Added 6.75%	1,140,103 $27.4 Million
Q4 2022 Feb 13, 2023	BUY	$16.14 - $23.55 $870,995 - $1.27 Million	53,965 Added 5.32%	1,068,053 $24.8 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $122,087 - $158,729	7,897 Added 0.78%	1,014,088 $16.2 Million
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $62,866 - $92,310	-4,421 Reduced 0.44%	1,006,191 $17.8 Million
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $190,748 - $249,525	11,090 Added 1.11%	1,010,612 $20.6 Million
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $682,797 - $833,012	39,017 Added 4.06%	999,522 $18.7 Million
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $227,306 - $325,144	-12,806 Reduced 1.32%	960,505 $19 Million
Q2 2021 Aug 17, 2021	BUY	$21.74 - $25.28 $919,297 - $1.07 Million	42,286 Added 4.54%	973,311 $23 Million
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $4.77 Million - $6.47 Million	247,848 Added 36.28%	931,025 $22.1 Million
Q4 2020 Feb 16, 2021	BUY	$17.83 - $22.29 $2.48 Million - $3.1 Million	139,268 Added 25.61%	683,177 $13.7 Million
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $2.17 Million - $2.86 Million	-137,462 Reduced 20.17%	543,909 $11.3 Million
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $249,358 - $378,463	-16,098 Reduced 2.31%	681,371 $11.9 Million
Q1 2020 May 15, 2020	BUY	$13.89 - $25.45 $9.41 Million - $17.2 Million	677,446 Added 3383.34%	697,469 $11.4 Million
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $214,246 - $445,311	20,023 New	20,023 $412,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $565,822 - $883,898	-53,279 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.58 - $18.72 $1.26 Million - $1.73 Million	-92,553 Reduced 63.47%	53,279 $807,000
Q4 2018 Feb 14, 2019	BUY	$14.78 - $19.68 $2.16 Million - $2.87 Million	145,832 New	145,832 $2.5 Million

Others Institutions Holding COLL

# of Institutions

253

Shares Held

37.2M

Call Options Held

61.1K

Put Options Held

5.8K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.1B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account